Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Barrett

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Cochrane Database of Systematic Reviews|September 6, 2020
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
The Cochrane Database of Systematic Reviews|March 7, 2017
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
The Cochrane Database of Systematic Reviews|December 10, 2014
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
Journal of Clinical Pharmacology|August 20, 2004
Ibandronate: a clinical pharmacological and pharmacokinetic updateJoanne Barrett, Eric Worth, Frieder Bauss, et al.
British Journal of Clinical Pharmacology|October 24, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacidsPaul Snell, Charles Oo, Al Dorr, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 16, 2021
Perception, experience and relationship with food and eating in adults with cystic fibrosisJoanne Barrett, Georgina Slatter, Joanna L Whitehouse, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
International Journal of Pharmaceutics|April 25, 2003
Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsulesCharles Oo, Paul Snell, Joanne Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot studyJean-Yves Reginster, Katie M Wilson, Etienne Dumont, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|September 6, 2020
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
The Cochrane Database of Systematic Reviews|March 7, 2017
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
The Cochrane Database of Systematic Reviews|December 10, 2014
Vitamin E supplementation in people with cystic fibrosisPeter O Okebukola, Sonal Kansra, Joanne Barrett
Journal of Clinical Pharmacology|August 20, 2004
Ibandronate: a clinical pharmacological and pharmacokinetic updateJoanne Barrett, Eric Worth, Frieder Bauss, et al.
British Journal of Clinical Pharmacology|October 24, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacidsPaul Snell, Charles Oo, Al Dorr, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 16, 2021
Perception, experience and relationship with food and eating in adults with cystic fibrosisJoanne Barrett, Georgina Slatter, Joanna L Whitehouse, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
International Journal of Pharmaceutics|April 25, 2003
Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsulesCharles Oo, Paul Snell, Joanne Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot studyJean-Yves Reginster, Katie M Wilson, Etienne Dumont, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Pageof 2